Philips buys US cardiac-implant firm Spectranetics for 1.9 billion euros

Spectranetics has developed a range of lasers and balloons for treating blockages in cardio and arterial vessels.

Published: 28th June 2017 02:30 PM  |   Last Updated: 28th June 2017 02:56 PM   |  A+A-

Philips said it would acquire Spectranetics or treating blockages in cardio and arterial vessels. (File Photo | AFP)


THE HAGUE: Dutch electronics giant Philips Wednesday announced it was buying for 1.9 billion euros ($2.2 billion) a specialist US company manufacturing ground-breaking treatments for heart and vascular diseases to broaden its health portfolio.

The Amsterdam-based company said it would acquire Spectranetics, which has developed a range of lasers and balloons for treating blockages in cardio and arterial vessels.

Philips also simultaneously launched a two-year share buyback scheme of up to 1.5 billion euros, which will start in the third quarter and represent a total of some 46.1 million shares.

Spectranetics, which has 900 employees, is trialling a drug-coated balloon to treat calcified blood vessels from the inside and expects to get FDA approval in the United States soon, said Philips chief executive officer, Frans van Houten.

"The drug-coated balloon segment is one of the fastest growing segments in peripheral vessel procedures," Van Houten told reporters on an early conference call.

The treatment had so far shown "fantastic performance," he said, and Spectranetics, which is headquartered in Colorado Springs, is expected to see some $300 million in revenues this year.

The Spectranetics portfolio will be joined with Philips' Volcano products to give the company "a nice line-up of devices for both heart, coronary and peripheral vascular" services. 

In combination with its image-guided products which allow doctors "to see inside the body and use these tools, we have a very compelling market position," Van Houten said.

Spectranetics said on its website that some seven million people around the world have been implanted with cardiac devices, and annually another 700,000 are fitted.

The two companies have entered into "a definite merger agreement" and the 1.9 billion euro acquisition will be paid for through a mixture of cash and debt, Houten added.

Philips, founded in 1891, was once best known for the manufacture of lightbulbs, electrical appliances and television sets.

But it pulled out of these activities in face of fierce competition from Asia to focus on health technology such as computer tomography, and diagnostic and molecular imaging.

Employing about 70,000 people, it also manufacturers such vital medical equipment as defibrillators, as well as household appliances -- from hi-tech toothbrushes to kitchen equipment. 

It listed its Philips Lighting division in May last year, netting proceeds of 750 million euros, and while it still holds a large stake in the Lighting division it intends to sell it entirely in the future.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp